If you decide on the grey market, that you are efficiently self-enrolling in an unmonitored safety trial. That's not essentially irrational—early adopters take chance for access. But it should be a aware choice, not an accident of not knowing the label.Grey market peptides present a real Predicament. They offer use of compounds which could give a